News
These certifications are awarded by the Association of Physicians of Barcelona and by the portalesmedicos.com website, respectively. Both organizations committees have praised the accuracy, scientific interest and quality of Bioibericas Blog devoted to osteoarthritis.The chondroprotection blog has had more than 5,500 visits from 3,000 unique users within less than six months.
The 2nd TEAM international symposium, held in Crete, Greece, was attended by more than 130 professionals from several different fields
The Heparin Science Business Unit will attend CPhI 2012 like every year. This year it takes place in Madrid from October 9th-11th, 2012.
Bioibericas Heparin Science has been invited as a speaker to the 5th Workshop on characterization of heparin products taking place on August 14th and 15th in the USP Headquarters located in Rockville, Maryland, USA.
It is a phase IV clinical trial currently being carried out in 38 medical centers in Spain, Germany, France and Poland. The objective of the MOVES (Multicenter Osteoarthritis InterVEntion trial with Sysadoas) it is to prove that combining chondroitin sulfate and glucosamine sulfate is as efficient as celecoxib for the treatment of moderate to severe pain in knee osteoarthritis.